ARTICLE | Company News
Cancer Genetics sales and marketing update
November 25, 2013 8:00 AM UTC
Cancer Genetics launched its fluorescence in situ hybridization (FISH)-based HPV-Associated Cancer Test (FHACT) to identify women with high risk of progressing to cervical cancer. The laboratory-devel...